Actor Has Terminal Cancer, “Game Of Thrones” Tweets Well-Wishes

“Game Of Thrones” actor Wilko Johnson has announced through his rep that he has terminal pancreatic cancer and has chosen not to receive chemotherapy. Johnson, who plays mute executioner S...
Actor Has Terminal Cancer, “Game Of Thrones” Tweets Well-Wishes
Written by Amanda Crum
  • “Game Of Thrones” actor Wilko Johnson has announced through his rep that he has terminal pancreatic cancer and has chosen not to receive chemotherapy.

    Johnson, who plays mute executioner Ser Ilyn Payne on the popular HBO series, is also a musician who plays guitar with British band Dr. Feelgood. His fans took to his Facebook page after manager Robert Hoy made the official announcement to express their grief and offer comfort in a scary time. The statement says that Johnson is currently in good health and spirits despite the diagnosis.

    I am very sad to announce that Wilko has recently been diagnosed with terminal cancer of the pancreas. He has chosen not to receive any chemotherapy.

    He is currently in good spirits, is not yet suffering any physical effects and can expect to enjoy at least another few months of reasonable health and activity.

    He has just set off on a trip to Japan; on his return we plan to complete a new CD, make a short tour of France, then give a series of farewell gigs in the UK. There is also a live DVD in the pipeline, filmed on the last UK tour.

    Wilko wishes to offer his sincere thanks for all the support he has had over his long career, from those who have worked with him to, above all, those devoted fans and admirers who have attended
    his live gigs, bought his recordings and generally made his life such an extraordinarily full and eventful experience.

    The official Game Of Thrones Twitter page has also reached out to send well-wishes to Johnson:

    While it’s not clear how long Johnson has, doctors don’t expect him to live much longer than a few months.

    Get the WebProNews newsletter delivered to your inbox

    Get the free daily newsletter read by decision makers

    Subscribe
    Advertise with Us

    Ready to get started?

    Get our media kit